4906.5000 65.50 (1.35%)
NSE Jun 27, 2025 15:31 PM
Volume: 113.9K
 

4906.50
1.35%
BOB Capital Markets Ltd.
Alkem Labs is a midsized pharma company (US$ 1bn sales) with India and the US as key markets. It is the market leader in several key acute segments in India. We believe a recovery in Alkem's India business profitability and rising US operating leverage would revive earnings to a 22% CAGR over FY19-FY21 (after a weak FY17-FY19). Post 40% underperformance to the Sensex in the last two years, the stock is trading at 12.3x FY21E EV/EBITDA, implying compelling risk-reward....
Alkem Laboratories Ltd. is trading below all available SMAs
More from Alkem Laboratories Ltd.
Recommended